Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. VTYX
VTYX logo

VTYX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VTYX News

Eli Lilly's Strategic Moves to Address Patent Cliff Risks

Feb 10 2026Fool

Eli Lilly's GLP-1 Drug Demand Soars Amid Future Concerns

Feb 10 2026NASDAQ.COM

Investigation into Proposed Sale of Ventyx Biosciences to Eli Lilly

Feb 05 2026Businesswire

Halper Sadeh LLC Investigates Multiple Companies for Potential Violations

Feb 05 2026Globenewswire

Monteverde Law Firm Investigates Multiple Mergers and Acquisitions

Feb 05 2026Globenewswire

Investor Rights Investigation: Multiple Company Transactions

Feb 05 2026PRnewswire

Halper Sadeh LLC Investigates Multiple Companies for Potential Violations

Feb 03 2026Globenewswire

Monteverde Law Firm Investigates Multiple M&A Transactions

Feb 03 2026Globenewswire

VTYX Events

02/13 15:10
Zomagen Biosciences Receives FDA Orphan Designation
Zomagen Biosciences Ltd, a wholly owned subsidiary of Ventyx Biosciences, received FDA orphan designation for a treatment of pericarditis, according to a post to the agency's website.
02/04 08:50
Significant Increases in Borrow Rates for Liquid Options
Latest data shows the largest indicative borrow rate increases among liquid option names include: PowerShares DB US Dollar Index Bullish Fund (UUP) 5.40% +1.09, VisionWave Holdings Inc (VWAV) 102.71% +1.00, T-REX 2X Long BMNR Daily Target ETF (BMNU) 30.17% +0.94, Star Bulk Carriers (SBLK) 2.23% +0.94, AXS TSLA Bear Daily ETF (TSLQ) 5.00% +0.60, GoPro (GPRO) 1.09% +0.56, Astex Pharmaceuticals Inc (ASTX) 13.96% +0.54, Gold Miners ETF (GDX) 1.16% +0.52, Tidal Trust II (IRE) 24.90% +0.48, and Ventyx Biosciences (VTYX) 0.80% +0.46.

VTYX Monitor News

No data

No data

VTYX Earnings Analysis

No Data

No Data

People Also Watch